“Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND”, J of Skin, vol. 8, no. 1, p. s329, Jan. 2024, doi: 10.25251/skin.8.supp.329.